HIGHLIGHTS
- who: Multidrug-Resistant Gram-Negative and collaborators from the Department of Pulmonary and Critical Care Medicine, Shengli Oilfield Central Hospital, Dongying, China, Department of Pharmacy, The Second Affiliated Hospital of Kunming Medical University, Kunming, China, Department of Pulmonary and Critical have published the Article: Ce derocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence, in the Journal: (JOURNAL) of 12/01/2022
- what: Four studies investigate the synergistic in_vitro activity of cefiderocol combined with other antimicrobial agents against Gram-negative bacteria (Tsuji et_al, 2016; Yamano et_al, 2020a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.